Skip to main content
OpenTrials

Clinical trial condition

Osteochondrodysplasias

Explore clinical trials studying Osteochondrodysplasias. Study availability and eligibility vary by location and protocol.

15 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Osteochondrodysplasias trial results

Recruiting

Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia

NCT07441876

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +5 more
Locations
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Nemours Children's Health Wilmington, Delaware, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Johns Hopkins Medicine Baltimore, Maryland, United States
View all 19 locations
View Trial Details
Recruiting

Prospective Clinical Assessment Study in Children With Hypochondroplasia

NCT06410976

Conditions
Bone Diseases, Bone Diseases, Developmental, Carbohydrate Metabolism, Inborn Errors, +16 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
View all 25 locations
View Trial Details
Recruiting

Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)

NCT07169279

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +19 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • University of Wisconsin Madison - Waisman Center Bone Dysplasia Clinic Madison, Wisconsin, United States
  • Murdoch Children's Research Institute Parkville, Victoria, Australia
View Trial Details
Enrolling by Invitation

An Interventional Study of Infigratinib in Children With Hypochondroplasia

NCT06873035

Conditions
Bone Diseases, Bone Diseases, Developmental, Carbohydrate Metabolism, Inborn Errors, +16 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
View all 24 locations
View Trial Details
Enrolling by Invitation

Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia

NCT07393373

Conditions
Bone Diseases, Bone Diseases, Developmental, Carbohydrate Metabolism, Inborn Errors, +16 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
View all 24 locations
View Trial Details
Enrolling by Invitation

Extension Study of Infigratinib in Children With Achondroplasia (ACH)

NCT05145010

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +15 more
Locations
  • USCF Benioff Children's Hospital, Oakland Oakland, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours Alfred I. Dupont Hospital for Children Wilmington, Delaware, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 31 locations
View Trial Details
Completed

Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

NCT04035811

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Benioff Children's Hospital Oakland Oakland, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours Alfred I. Dupont Hospital for Children Wilmington, Delaware, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
View all 32 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

NCT06164951

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • QED Investigative Site San Francisco, California, United States
  • QED Investigative Site Aurora, Colorado, United States
  • QED Investigative Site Baltimore, Maryland, United States
  • QED Investigative Site Columbia, Missouri, United States
View all 27 locations
View Trial Details
Completed

Study of Infigratinib in Children With Achondroplasia

NCT04265651

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • Nemours Alfred I. Dupont Hospital for Children Wilmington, Delaware, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View all 19 locations
View Trial Details

Related conditions